论文部分内容阅读
1918年1月23日,美国纽约市一个女孩诞生了。有谁会想到,70年后,1988年10月10日,诺贝尔评奖委员会向全世界宣布:将本年度生理学或医学奖授于这个已是著名有机药物化学家的优秀女科学家,格特鲁德·贝利·伊莱昂(Gertooude Belle Elion),以表彰她在研制治疗癌症、痛风、疟疾或病毒性疾病药物方面的成就。评委会在获奖评语中指出了她所从事的研究与众不同:多年来新药的研制都是把天然药的分子结构加以改选,而伊莱昂和她的同事们则是根据生理生化的基础研究结果而创制新药,因此提出了一个更合理的研究途径和原理。著名科学家美国国立癌症研究所所长Devite对此发表评论认为:“这是一个十分英明的决定。”
January 23, 1918, a girl in New York City, USA was born. Who would have thought, 70 years later, on October 10, 1988, the Nobel Committee on Awards announced to the world: this year’s Physiology or Medicine Prize awarded to this is the famous organic medicinal chemist outstanding female scientist, Ge Rulude Gertooude Belle Elion in recognition of her achievements in developing drugs to treat cancer, gout, malaria or viral diseases. The jury pointed out in her award-winning commentary that the research she is engaged in is different: the development of new drugs over the years has been to re-elect the molecular structure of natural medicines, and Elijah and her colleagues are based on basic research in physiology and biochemistry As a result, a new drug was invented, so a more reasonable research approach and principle was proposed. Well-known scientist Devite, director of the National Cancer Institute, commented: “This is a very wise decision.”